Brief: Sanofi To Explore Acquisition Of Cancer Drugmaker Mirati - Bloomberg News
Oct 5 (Reuters) -
* SANOFI TO EXPLORE ACQUISITION OF CANCER DRUGMAKER MIRATI -
BLOOMBERG NEWS
Source text: [https://shorturl.at/lrOQX]
Further company coverage: MRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mirati Therapeutics
See all newsBrief: European Commission Approves KRAZATI As A Targeted Treatment For Non-Small Cell Lung Cancer
US FDA turns down Amgen lung cancer drug Lumakras for full approval (updated)
US FDA turns down Amgen lung cancer drug Lumakras for full approval
Brief: Mirati Stockholders Voted 'For' Proposal To Adopt Deal Between Co, Bristol-Myers Squibb
Mirati's lung cancer drug gets EU's regulatory backing (updated)